Treatment of acute Kawasaki disease: Aspirin's role in the febrile stage revisited

Pediatrics

Volumn 114, Issue 6, 2004, Pages

  Hsieh, Kai Sheng ^a,b   Weng, Ken Pen ^a,c   Lin, Chu Chuan ^a   Huang, Ta Cheng ^a   Lee, Cheng Liang ^a   Huang, Shih Ming ^a,d,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d Puli Christian Hospital   (Taiwan)

^e Department of Pediatrics ^*  (Taiwan)

Author keywords

Aspirin; Coronary aneurysm; Immunoglobulin; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; PARACETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE DISEASE; ARTICLE; CHRONOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; DRUG EFFECT; DRUG EXPOSURE; DRUG INFUSION; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; FEVER; HUMAN; INCIDENCE; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; CHILD; DRUG COMBINATION;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES;

EID: 16244389174     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1037     Document Type: Article

References (25)

1. De Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998;133:254-258
2. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341-347
3. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639
4. Onouchi Z, Kawasaki T. Overview of pharmacological treatment of Kawasaki disease. Drugs. 1999;58:813-822
5. Saulsbury FT. Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome. Clin Pediatr (Phila). 2002;41:597-601
6. Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87:1776-1780
7. Kusakawa S, Tatara K. Efficacies and risks of aspirin in the treatment of the Kawasaki disease. Prog Clin Biol Res. 1987;250:401-413
8. Research Committee on Kawasaki disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Ministry of Health and Welfare; 1984
9. Arjunan K, Daniels SR, Meyer RA, Schwartz DC, Barron H, Kaplan S. Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. J Am Coll Cardiol. 1986;8:1119-1124
10. Burns JC, Capparelli EV, Brown JA, et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J. 1998;17:1144-1148
11. Falcini F, Ermini M, Trapani S, et al. Efficacy and safety of immunoglobulin retreatment in Kawasaki disease. J Pediatr. 1994;125:672-673
12. Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med. 2000;154:694-699
13. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroid. J Pediatr. 1996;128:146-149
14. Shulman ST, Rowley AH. Advances in Kawasaki disease. Eur J Pediatr. 2004;163:285-291
15. Sundel RP, Burns JC, Baker A, et al. Gamma globulin retreatment in Kawasaki disease. J Pediatr. 1993;123:657-659
16. Hung JJ, Chiu CH. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature. Ann Trop Paediatr. 2004;24:89-93
17. Lang B, Duffy CM. Controversies in the management of Kawasaki disease. Best Pract Res Clin Rheumatol. 2002;16:427-442
18. Melish ME. Comparison of low dose aspirin vs. high dose aspirin as an adjunct to intravenous gamma globulin in the treatment of Kawasaki syndrome. Pediatr Res. 1992;31:170A
19. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease. Pediatrics. 1995;96:1057-1061
20. Muta H, Ishii M, Egami K, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr. 2004;144:496-499
21. Matsubara T, Mason W, Kashani IA, Kligerman M, Burns JC. Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. J Pediatr. 1996;128:701-703
22. Lee JH, Hung HY, Huang FY. Kawasaki disease with Reye syndrome: report of one case. Acta Paed Sin. 1992;33:67-71
23. Mulberg AE, Verhave M. Identification and treatment of nonsteroidal anti-inflammatory drug-induced gastroduodenal injury in children. Am J Dis Child. 1993;147:1280-1281
24. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics. 2001;107(3). Available at: www.pediatrics.org/cgi/content/full/107/3/e33
25. Lue HC, Philip S, Chen MR, Wang JK, Wu MH. Surveillance of Kawasaki disease in Taiwan and review of the literature. Acta Paediatr Taiwan. 2004;45:8-14